This is a Validated Antibody Database (VAD) review about mouse B7 2, based on 256 published articles (read how Labome selects the articles), using B7 2 antibody in all methods. It is aimed to help Labome visitors find the most suited B7 2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
B7 2 synonym: B7; B7-2; B7.2; B70; CLS1; Cd28l2; ETC-1; Ly-58; Ly58; MB7; MB7-2; TS/A-2

others
  • flow cytometry; mouse; loading ...; fig 6b
B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 6b). Acta Neuropathol (2020) ncbi
  • flow cytometry; mouse; loading ...; fig s4
B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig s4). Sci Adv (2019) ncbi
  • flow cytometry; mouse; loading ...; fig 4g
B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 4g). Sci Rep (2019) ncbi
BioLegend
rat monoclonal (GL-1)
  • immunohistochemistry; mouse; loading ...; fig 4a
BioLegend B7 2 antibody (Biolegend, 105011) was used in immunohistochemistry on mouse samples (fig 4a). Nat Commun (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples at 1:200. J Immunother Cancer (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 3b
BioLegend B7 2 antibody (BioLegend, 105014) was used in flow cytometry on mouse samples (fig 3b). Brain Commun (2021) ncbi
rat monoclonal (PO3)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend B7 2 antibody (Biolegend, 105109) was used in flow cytometry on mouse samples (fig 3a). Front Pharmacol (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:400; loading ...; fig s6c
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples at 1:400 (fig s6c). Nat Commun (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend B7 2 antibody (Biolegend, 105013) was used in flow cytometry on mouse samples (fig 3b). Vaccines (Basel) (2021) ncbi
rat monoclonal (GL-1)
  • mass cytometry; mouse; loading ...; fig 4g
BioLegend B7 2 antibody (Biolegend, 105002) was used in mass cytometry on mouse samples (fig 4g). Cancer Cell (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:100; fig s6g
BioLegend B7 2 antibody (Biolegend, 105030) was used in flow cytometry on mouse samples at 1:100 (fig s6g). Cell Rep (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:100; loading ...; fig 2a
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples at 1:100 (fig 2a). Sci Rep (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:100; loading ...; fig s5-2g
BioLegend B7 2 antibody (BioLegend, 105014) was used in flow cytometry on mouse samples at 1:100 (fig s5-2g). elife (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s7c
BioLegend B7 2 antibody (Biolegend, 105005) was used in flow cytometry on mouse samples (fig s7c). Nat Commun (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 6c
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 6c). Front Immunol (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; human; loading ...
BioLegend B7 2 antibody (Biolegend, 105007) was used in flow cytometry on human samples . J Immunother Cancer (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s3d
BioLegend B7 2 antibody (Biolegend, 105014) was used in flow cytometry on mouse samples (fig s3d). Cell (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend B7 2 antibody (BioLegend, 105007) was used in flow cytometry on mouse samples (fig 4f). Blood (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 5g
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 5g). Front Immunol (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:200; loading ...; fig s2-2a
BioLegend B7 2 antibody (BioLegend, GL1) was used in flow cytometry on mouse samples at 1:200 (fig s2-2a). elife (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 6
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 6). Front Immunol (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples . Mucosal Immunol (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 6b
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 6b). Acta Neuropathol (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:800; loading ...; fig 2e
BioLegend B7 2 antibody (BioLegend, 105006) was used in flow cytometry on mouse samples at 1:800 (fig 2e). elife (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 2b). Nat Commun (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 1f, s2b
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 1f, s2b). BMC Immunol (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 4c). BMC Gastroenterol (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1 ug/ml; loading ...; fig 3e
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples at 1 ug/ml (fig 3e). Science (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s3a, s3b, s3c, s4a
BioLegend B7 2 antibody (BioLegend, 105012) was used in flow cytometry on mouse samples (fig s3a, s3b, s3c, s4a). Cancers (Basel) (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:200; loading ...; fig 4b
BioLegend B7 2 antibody (BioLegend, 105014) was used in flow cytometry on mouse samples at 1:200 (fig 4b). Nat Commun (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:100; loading ...; fig s6c, s9
BioLegend B7 2 antibody (Biolegend, 105017) was used in flow cytometry on mouse samples at 1:100 (fig s6c, s9). Nat Commun (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s4b
BioLegend B7 2 antibody (BioLegend, GL1) was used in flow cytometry on mouse samples (fig s4b). Science (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s4
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig s4). Sci Adv (2019) ncbi
rat monoclonal (GL-1)
  • mass cytometry; mouse; 0.75 ug/ml; loading ...; fig 5d
BioLegend B7 2 antibody (Biolegend, GL-1) was used in mass cytometry on mouse samples at 0.75 ug/ml (fig 5d). Science (2019) ncbi
rat monoclonal (GL-1)
  • mass cytometry; mouse; loading ...; fig 1a, 1c, s1
BioLegend B7 2 antibody (Biolegend, GL1) was used in mass cytometry on mouse samples (fig 1a, 1c, s1). Cell Rep (2019) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend B7 2 antibody (BioLegend, 105012) was used in flow cytometry on mouse samples (fig 3d). J Exp Med (2020) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 4g
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 4g). Sci Rep (2019) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend B7 2 antibody (Biolegend, 105008) was used in flow cytometry on mouse samples (fig 1a). Front Immunol (2019) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 2g
BioLegend B7 2 antibody (Biolegend, 105035) was used in flow cytometry on mouse samples (fig 2g). Oncoimmunology (2019) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:200; loading ...; fig ex5a
BioLegend B7 2 antibody (BioLegend, 105011) was used in flow cytometry on mouse samples at 1:200 (fig ex5a). Nature (2019) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s13a
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig s13a). Science (2019) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s4h
BioLegend B7 2 antibody (Biolegend, 105007) was used in flow cytometry on mouse samples (fig s4h). Sci Rep (2019) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend B7 2 antibody (BioLegend, 105011) was used in flow cytometry on mouse samples (fig 1a). Immunity (2019) ncbi
rat monoclonal (PO3)
  • mass cytometry; mouse; loading ...; fig 5s2b
BioLegend B7 2 antibody (Bio Legend, PO3) was used in mass cytometry on mouse samples (fig 5s2b). elife (2019) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig s1c). J Immunol (2019) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend B7 2 antibody (Biolegend, 105022) was used in flow cytometry on mouse samples (fig 2e). Cell Rep (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s5
BioLegend B7 2 antibody (Biolegend, 10503) was used in flow cytometry on mouse samples (fig s5). Nat Commun (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:300; loading ...; fig s9a, s9b
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples at 1:300 (fig s9a, s9b). Nat Commun (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 5d
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 5d). Front Immunol (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:100; loading ...; fig 5e
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples at 1:100 (fig 5e). J Pathol (2019) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:200; loading ...; fig 4h
BioLegend B7 2 antibody (BioLegend, GL1) was used in flow cytometry on mouse samples at 1:200 (fig 4h). Nat Commun (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 4b). PLoS ONE (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend B7 2 antibody (Biolegend, 105028) was used in flow cytometry on mouse samples (fig 2e). J Clin Invest (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 4a). Front Immunol (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:150; loading ...; fig s6a
BioLegend B7 2 antibody (BioLegend, 105007) was used in flow cytometry on mouse samples at 1:150 (fig s6a). Nat Commun (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:100; loading ...; fig s1
BioLegend B7 2 antibody (Biolegend, GL1) was used in flow cytometry on mouse samples at 1:100 (fig s1). Nat Commun (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s6a
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig s6a). Cell Metab (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:200; loading ...; fig s1b
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples at 1:200 (fig s1b). Nat Commun (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 6b
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 6b). J Immunol (2018) ncbi
rat monoclonal (PO3)
  • flow cytometry; mouse; loading ...; fig 9b
BioLegend B7 2 antibody (BioLegend, PO3) was used in flow cytometry on mouse samples (fig 9b). J Exp Med (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 2c
BioLegend B7 2 antibody (BioLegend, 105021) was used in flow cytometry on mouse samples (fig 2c). Cell (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s1b
BioLegend B7 2 antibody (Biolegend, Gl-1) was used in flow cytometry on mouse samples (fig s1b). Science (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig s6f
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig s6f). JCI Insight (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 5b
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend B7 2 antibody (Biolegend, 105008) was used in flow cytometry on mouse samples (fig 5b). Cell Death Dis (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s4d
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig s4d). Eur J Immunol (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:200; loading ...; fig s8
BioLegend B7 2 antibody (Biolegend, 105030) was used in flow cytometry on mouse samples at 1:200 (fig s8). Nat Cell Biol (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 5c). Cancer Res (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig s2b). J Exp Med (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 1c
In order to show that TLR4 signals through the BCR leading to activation of SYK, ERK, and AKT as well as through MYD88 leading to activation of NFkappaB, BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend B7 2 antibody (BioLegend, GL1) was used in flow cytometry on mouse samples (fig 2b). Immunology (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 5a
In order to demonstrate that Ephrin-B1 is a specific marker of mature germinal center B cells, BioLegend B7 2 antibody (BioLegend, 105008) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:200; loading ...; fig 2r
BioLegend B7 2 antibody (BioLegend, 105015) was used in flow cytometry on mouse samples at 1:200 (fig 2r). J Neurosci (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 7a
In order to elucidate the role of interferon regulatory factor 4 in dendritic cells, BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 7a). J Cell Biol (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 2c
In order to investigate temporal changes of the CD11b+ cell populations in the brain and protein expression of the immunomodulatory factor galectin-3 in neonatal hypoxia-ischemia brain tissue, BioLegend B7 2 antibody (BioLegend, 105028) was used in flow cytometry on mouse samples (fig 2c). Front Cell Neurosci (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 1b
BioLegend B7 2 antibody (BioLegend, GL1) was used in flow cytometry on mouse samples (fig 1b). Sci Rep (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig s2b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 2
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 2). Oncotarget (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s3b
In order to investigate the role of mTOR in plasma cell differentiation and antibody production in RAPTOR deficient cells., BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig s3b). J Clin Invest (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 6d
In order to assess the effects of a genetically encoded chimeric MyD88/CD40 adjuvant, BioLegend B7 2 antibody (BioLegend, 105030) was used in flow cytometry on mouse samples (fig 6d). PLoS ONE (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 4b
In order to probe how neutrophil extracellular traps modulate the rheumatoid arthritis-associated autoimmune response, BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 4b). Eur J Immunol (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 4
In order to test if a diet high in fats affects the development of respiratory tolerance, BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 4e
In order to examine the impact of emergency granulopoiesis on T and B cell function, BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 4e). J Exp Med (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 1c
BioLegend B7 2 antibody (Biolegend, 105008) was used in flow cytometry on mouse samples (fig 1c). J Virol (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 6
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 6). J Immunol (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig s2f
In order to elucidate the role of B cells in the initiation of central nervous system autoimmunity, BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig s2f). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...
In order to test if administration of exogenous IL-19 reduces progression of preformed atherosclerotic plaque, BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples . Am J Pathol (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 3e
In order to compare the capacity of induced T regulatory and T helper 17 cells to develop in a T cell model of colitis, BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 3e). J Immunol (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 2
In order to study dendritic cells in Sirt6 knock out mice, BioLegend B7 2 antibody (Biolegend, GL1) was used in flow cytometry on mouse samples (fig 2). Aging (Albany NY) (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig s3
In order to analyze the promotion of the development of pancreatic neoplasia by IL35-producing B cells, BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig s3). Cancer Discov (2016) ncbi
rat monoclonal (PO3)
  • flow cytometry; mouse; fig 1
In order to determine the promotion of the formation of conjugates between transformed T helper cells and B lymphoma cells by murid gammaherpesvirus latency-associated protein M2, BioLegend B7 2 antibody (BioLegend, PO3) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2015) ncbi
rat monoclonal (GL-1)
  • immunohistochemistry - frozen section; mouse; fig 4
BioLegend B7 2 antibody (BioLegend, GL-1) was used in immunohistochemistry - frozen section on mouse samples (fig 4). Cancer Res (2015) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 8
In order to study engineered anti-melanoma vaccines that modulate cytokine priming and silence PD-L1 simultaneously by use of ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy, BioLegend B7 2 antibody (BioLegend, 105007) was used in flow cytometry on mouse samples (fig 8). Oncoimmunology (2014) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 1
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 1). J Immunol (2015) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 6
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples (fig 6). J Immunol (2015) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 1
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 1). Biochem Biophys Res Commun (2015) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 4
BioLegend B7 2 antibody (BioLegend, GL1) was used in flow cytometry on mouse samples (fig 4). J Immunol (2015) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 4
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 4). J Immunol (2015) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse
BioLegend B7 2 antibody (BioLegend, GL-1) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 5
BioLegend B7 2 antibody (Biolegend, GL-1) was used in flow cytometry on mouse samples (fig 5). J Heart Lung Transplant (2015) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse
BioLegend B7 2 antibody (BioLegend, GL1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (GL-1)
BioLegend B7 2 antibody (BioLegend, 105039) was used . J Neurosci (2014) ncbi
Invitrogen
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 4c
Invitrogen B7 2 antibody (eBioscience, 25-0862-82) was used in flow cytometry on mouse samples (fig 4c). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 1:100; loading ...; fig 5f
Invitrogen B7 2 antibody (eBioscience, 56-0862-82) was used in flow cytometry on mouse samples at 1:100 (fig 5f). Cell Prolif (2021) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen B7 2 antibody (eBioscience, GL-1) was used in flow cytometry on mouse samples (fig 2d). J Alzheimers Dis (2020) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen B7 2 antibody (eBioscience, GL-1) was used in flow cytometry on mouse samples (fig 2d). J Alzheimers Dis (2020) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 6c
Invitrogen B7 2 antibody (Thermo Fisher, 17-0862-82) was used in flow cytometry on mouse samples (fig 6c). Cell (2019) ncbi
rat monoclonal (PO3.1)
  • flow cytometry; mouse; loading ...; fig s6c
Invitrogen B7 2 antibody (Thermo Fisher, 12-0861-81) was used in flow cytometry on mouse samples (fig s6c). Cell (2019) ncbi
rat monoclonal (PO3.1)
  • flow cytometry; mouse; loading ...; fig 2g
Invitrogen B7 2 antibody (Ebioscience, 12-0861-82) was used in flow cytometry on mouse samples (fig 2g). Oncoimmunology (2019) ncbi
rat monoclonal (GL1)
  • flow cytometry; human; loading ...; fig s4b
Invitrogen B7 2 antibody (EBioscience, 25-0862-80) was used in flow cytometry on human samples (fig s4b). Breast Cancer Res (2019) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 1b, 1e
Invitrogen B7 2 antibody (eBioscience, GL-1) was used in flow cytometry on mouse samples (fig 1b, 1e). Front Immunol (2019) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 1b, 1e
Invitrogen B7 2 antibody (eBioscience, GL-1) was used in flow cytometry on mouse samples (fig 1b, 1e). Front Immunol (2019) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 6c
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (fig 6c). Immune Netw (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 6c
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (fig 6c). Immune Netw (2018) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 1:100; loading ...; fig 8c
Invitrogen B7 2 antibody (eBioscience, 12-0862-82) was used in flow cytometry on mouse samples at 1:100 (fig 8c). Nat Commun (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig e5c
Invitrogen B7 2 antibody (eBiosciences, GL1) was used in flow cytometry on mouse samples (fig e5c). Nature (2018) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig e5c
Invitrogen B7 2 antibody (eBiosciences, GL1) was used in flow cytometry on mouse samples (fig e5c). Nature (2018) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen B7 2 antibody (Thermofisher Scientific, GL1) was used in flow cytometry on mouse samples (fig s2a). Front Immunol (2018) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen B7 2 antibody (Thermofisher Scientific, GL1) was used in flow cytometry on mouse samples (fig s2a). Front Immunol (2018) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 2d
Invitrogen B7 2 antibody (Invitrogen, GL1) was used in flow cytometry on mouse samples (fig 2d). J Immunol (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 2d
Invitrogen B7 2 antibody (Invitrogen, GL1) was used in flow cytometry on mouse samples (fig 2d). J Immunol (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen B7 2 antibody (eBioscience, GL-1) was used in flow cytometry on mouse samples (fig 5d). J Leukoc Biol (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen B7 2 antibody (eBioscience, GL-1) was used in flow cytometry on mouse samples (fig 5d). J Leukoc Biol (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 3a
In order to elucidate how schistosome-induced B cells protect against allergic airway inflammation, Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (fig 3a). Int J Parasitol (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen B7 2 antibody (eBiosciences, GL1) was used in flow cytometry on mouse samples (fig 5d). J Exp Med (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen B7 2 antibody (eBiosciences, GL1) was used in flow cytometry on mouse samples (fig 5d). J Exp Med (2017) ncbi
rat monoclonal (GL-1)
  • immunohistochemistry - frozen section; mouse; loading ...; fig S8b
In order to report the differential effector function by exosomes in communicating the toll like receptor activation state of the original activated cell, Invitrogen B7 2 antibody (Thermo Fisher, MA1-10299) was used in immunohistochemistry - frozen section on mouse samples (fig S8b). Sci Rep (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 2a
In order to examine the localization and function of FHL2 in natural killer cells, Invitrogen B7 2 antibody (Affymetrix eBioscience, GL1) was used in flow cytometry on mouse samples (fig 2a). Front Immunol (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 3a
In order to test the effect of paeoniflorin in experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis, Invitrogen B7 2 antibody (eBioscience, 11-0862) was used in flow cytometry on mouse samples (fig 3a). Sci Rep (2017) ncbi
rat monoclonal (GL-1)
  • immunohistochemistry; rat; 1:100; loading ...; fig 6a
In order to study the effects of a high-fat diet on the spleen and immune system and to determine the protective effects of chronic treatment with vitamin D, Invitrogen B7 2 antibody (Thermo Fischer Scientific, MA1-10299) was used in immunohistochemistry on rat samples at 1:100 (fig 6a). Pathophysiology (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; 1:100; loading ...; fig S5
In order to find that C-type lectin dendritic cell immunoreceptor is required to modulate lung inflammation and bacterial burden in tuberculosis, Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples at 1:100 (fig S5). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (GL1)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3a
In order to investigate temporal changes of the CD11b+ cell populations in the brain and protein expression of the immunomodulatory factor galectin-3 in neonatal hypoxia-ischemia brain tissue, Invitrogen B7 2 antibody (eBioscience, 14-0862) was used in immunohistochemistry on mouse samples at 1:200 (fig 3a). Front Cell Neurosci (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 2b
In order to study the ability of lymphocyte-derived microparticles to modulate the gene expression pattern of angiogenesis-related factors in macrophages, Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (fig 2b). Sci Rep (2016) ncbi
rat monoclonal (PO3.1)
  • flow cytometry; mouse; loading ...; fig 2b
In order to study cancer-testis antigen expression in a mouse model of prostate cancer, Invitrogen B7 2 antibody (Invitrogen, P0.3) was used in flow cytometry on mouse samples (fig 2b). Prostate (2017) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 6c
In order to investigate strains of Listeria monocytogenes that activate necrosis, apoptosis, or pyroptosis and study the role of CD8 positive T cells in these processes, Invitrogen B7 2 antibody (ebioscience, GL1) was used in flow cytometry on mouse samples (fig 6c). Infect Immun (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 3e
In order to study the role of miR-7 in acute lung injury, Invitrogen B7 2 antibody (ebioscience, 17-0862-81) was used in flow cytometry on mouse samples (fig 3e). Front Immunol (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 6
In order to report that metformin inhibits advanced glycation end product-induced inflammatory response through AMPK activation and RAGE/NFkappaB pathway suppression, Invitrogen B7 2 antibody (eBioscience, 12-0862) was used in flow cytometry on mouse samples (fig 6). J Diabetes Res (2016) ncbi
rat monoclonal (PO3.1)
  • flow cytometry; mouse; 1:80; loading ...; fig 1a
Invitrogen B7 2 antibody (eBioscience, PO3.1) was used in flow cytometry on mouse samples at 1:80 (fig 1a). PLoS ONE (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; fig 4B
In order to study the contribution of CXCR6/CXCL16 interactions in glycolipid-dependent invariant natural killer cell activation and tumor control, Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (fig 4B). Oncoimmunology (2016) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 1a
In order to determine the role of Id3 in germinal center B cells, Invitrogen B7 2 antibody (BD Pharmingen or eBioscience, GL1) was used in flow cytometry on mouse samples (fig 1a). Mol Cell Biol (2016) ncbi
rat monoclonal (PO3.1)
  • flow cytometry; mouse; loading ...; fig s1
In order to examine the effects of mesenchymal stromal cell-derived extracellular vesicles on bone marrow radiation damage, Invitrogen B7 2 antibody (eBioscience, 12-0861-82) was used in flow cytometry on mouse samples (fig s1). Leukemia (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 4a
In order to compare methods of generating tumor lysates/cells used for pulsing dendritic cell vaccines, Invitrogen B7 2 antibody (eBioscience, 12-0862-83) was used in flow cytometry on mouse samples (fig 4a). Oncoimmunology (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 2
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (fig 2). J Immunol (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig s9
Invitrogen B7 2 antibody (eBioscience, 17-0862-82) was used in flow cytometry on mouse samples (fig s9). Sci Rep (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 1:100; fig 2
In order to determine the affects of dendritic cell migration in vitro by loss of gadkin, Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples at 1:100 (fig 2). PLoS ONE (2015) ncbi
rat monoclonal (PO3.1)
  • flow cytometry; mouse
In order to identify the sequence motif of B class phosphodiester oligodeoxyribonucleotides that govern mouse TLR9 activation, Invitrogen B7 2 antibody (eBioscience, PO3.1) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
In order to identify the sequence motif of B class phosphodiester oligodeoxyribonucleotides that govern mouse TLR9 activation, Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 4
Invitrogen B7 2 antibody (eBioscience, 12-0862) was used in flow cytometry on mouse samples (fig 4). Biomed Res Int (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
In order to assess the role of GPA33 in intestinal barrier function using KO mice, Invitrogen B7 2 antibody (Life Technologies, A15412) was used in flow cytometry on mouse samples . Dis Model Mech (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig s3
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (fig s3). Nature (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
In order to study the role of melanoma cell surface-associated calreticulin in melphalan-induced antitumor immunity, Invitrogen B7 2 antibody (eBioscience, 17-0862-81) was used in flow cytometry on mouse samples . Cancer Res (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 2
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; tbl s3
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (tbl s3). PLoS ONE (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 3
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (fig 3). Carbohydr Polym (2015) ncbi
rat monoclonal (PO3.1)
  • flow cytometry; mouse
Invitrogen B7 2 antibody (eBioscience, PO3.1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples . Mucosal Immunol (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 4e
In order to investigate the application of intra-dermal mesoporous silica rods in immune modulation., Invitrogen B7 2 antibody (eBioscience, 12-0862) was used in flow cytometry on mouse samples (fig 4e). Nat Biotechnol (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples . Hum Immunol (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 2
Invitrogen B7 2 antibody (eBiosciences, GLI) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 3c
In order to test the efficacy of combining different monoclonal antibodies to treat cancer, Invitrogen B7 2 antibody (ebioscience, 14-0862-82) was used in flow cytometry on mouse samples (fig 3c). Clin Cancer Res (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 3
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (fig 3). J Immunol (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 1:100; fig 2
Invitrogen B7 2 antibody (eBioscience, 12-0862-85) was used in flow cytometry on mouse samples at 1:100 (fig 2). PLoS ONE (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; human
Invitrogen B7 2 antibody (eBioscience, 12-0862-82) was used in flow cytometry on human samples . J Immunol (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 1:50
Invitrogen B7 2 antibody (eBioscience, 12-0862-82) was used in flow cytometry on mouse samples at 1:50. Acta Neuropathol Commun (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 3
In order to elucidate the role of dendritic cells in cancer immunosurveillance failure, Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (fig 3). Immunol Cell Biol (2013) ncbi
rat monoclonal (RMMP-2)
  • flow cytometry; mouse; fig 1d
In order to compare two dendritic cell modification strategies to inhibit allogeneic T-cell proliferation, Invitrogen B7 2 antibody (Caltag, RMMP-2) was used in flow cytometry on mouse samples (fig 1d). Eur J Immunol (2013) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig s3
In order to investigate the different immune responses when mice are infected with type I or type II strains of T. gondii, Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (fig s3). J Immunol (2010) ncbi
rat monoclonal (RMMP-2)
  • flow cytometry; mouse; fig 5
In order to test if upregulation of major histocompatibility complex class II and costimulatory molecules in the retina contributes to the regulation of CD4 T cells, Invitrogen B7 2 antibody (Invitrogen, RMMP-2) was used in flow cytometry on mouse samples (fig 5). Infect Immun (2010) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 6
In order to elucidate the role of AUF1 in the immune system, Invitrogen B7 2 antibody (eBioScience, GL1) was used in flow cytometry on mouse samples (fig 6). BMC Immunol (2010) ncbi
rat monoclonal (RMMP-2)
  • flow cytometry; mouse
In order to study the effect of inactivated Parapoxvirus ovis on dendritic cells, Invitrogen B7 2 antibody (Caltag Laboratories, RMMP-2) was used in flow cytometry on mouse samples . J Virol (2009) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 4
Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples (fig 4). J Immunol (2009) ncbi
rat monoclonal (PO3.1)
  • flow cytometry; mouse
In order to investigate crosstalk between that osteoclasts and T cells, Invitrogen B7 2 antibody (eBioscience, PO3.1) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (GL1)
  • immunocytochemistry; mouse
Invitrogen B7 2 antibody (eBioscience, GL-1) was used in immunocytochemistry on mouse samples . Cell Host Microbe (2009) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
In order to examine the origin and development of Aire positive medullary thymic epithelial cells, Invitrogen B7 2 antibody (eBioscience, GL1) was used in flow cytometry on mouse samples . Nat Immunol (2007) ncbi
rat monoclonal (RMMP-2)
  • flow cytometry; mouse; fig 6
In order to study T cell responses in CD154-/- mice treated with radiation-attenuated S. mansoni larvae, Invitrogen B7 2 antibody (Caltag, RMMP-2) was used in flow cytometry on mouse samples (fig 6). J Immunol (2006) ncbi
rat monoclonal (PO3.1)
  • flow cytometry; mouse; fig 2
In order to clone and characterize Siglec-H, Invitrogen B7 2 antibody (eBioscience, PO3.1) was used in flow cytometry on mouse samples (fig 2). Blood (2006) ncbi
rat monoclonal (PO3.1)
  • flow cytometry; mouse; fig 5
  • flow cytometry; human
Invitrogen B7 2 antibody (eBioscience, PO3.1) was used in flow cytometry on mouse samples (fig 5) and in flow cytometry on human samples . J Immunol (2005) ncbi
rat monoclonal (RMMP-2)
  • flow cytometry; mouse; fig 1
In order to investigate how products released by schistosome larvae affect dendritic cells, Invitrogen B7 2 antibody (Caltag, RMMP-2) was used in flow cytometry on mouse samples (fig 1). Infect Immun (2005) ncbi
rat monoclonal (RMMP-2)
  • flow cytometry; mouse; fig 4
In order to investigate how IL-10 regulates IL-12 production in skin treated with radiation-attenuated schistosomes, Invitrogen B7 2 antibody (Caltag, RMMP-2) was used in flow cytometry on mouse samples (fig 4). Int Immunol (2003) ncbi
rat monoclonal (RMMP-2)
  • flow cytometry; mouse
In order to assess the contribution of DC function in non-obese diabetic mice, Invitrogen B7 2 antibody (Caltag, RMMP-2) was used in flow cytometry on mouse samples . Clin Exp Immunol (2003) ncbi
rat monoclonal (RMMP-2)
  • flow cytometry; mouse; fig 2
In order to investigate homeostatic B cell proliferation, Invitrogen B7 2 antibody (Caltag, RMMP-2) was used in flow cytometry on mouse samples (fig 2). J Immunol (2002) ncbi
rat monoclonal (RMMP-2)
  • flow cytometry; mouse; fig 5
In order to report that histone deacetylase inhibitors alter the acetylation of histones and enhance the expression of several genes on tumor cells, Invitrogen B7 2 antibody (Caltag, RMMP-2) was used in flow cytometry on mouse samples (fig 5). J Immunol (2000) ncbi
rat monoclonal (GL-1)
  • flow cytometry; mouse
In order to generate and characterize mice deficient for CD37, Invitrogen B7 2 antibody (Biosource, GL1) was used in flow cytometry on mouse samples . Mol Cell Biol (2000) ncbi
rat monoclonal (RMMP-2)
  • flow cytometry; mouse; tbl 1
In order to examine the contribution of different DC subsets during infection with Cryptococcus neoformans, Invitrogen B7 2 antibody (Caltag, RMMP-2) was used in flow cytometry on mouse samples (tbl 1). J Immunol (2000) ncbi
Abcam
mouse monoclonal (BU63)
  • flow cytometry; rat; loading ...; fig 1b
Abcam B7 2 antibody (Abcam, ab213044) was used in flow cytometry on rat samples (fig 1b). Biosci Rep (2020) ncbi
rat monoclonal (GL-1)
  • immunohistochemistry - free floating section; mouse; loading ...; fig 4g
Abcam B7 2 antibody (Abcam, ab119857) was used in immunohistochemistry - free floating section on mouse samples (fig 4g). J Neuroinflammation (2020) ncbi
Miltenyi Biotec
rat monoclonal (PO3.3)
  • flow cytometry; mouse; loading ...; fig s9
Miltenyi Biotec B7 2 antibody (Miltenyi, 130-102-558) was used in flow cytometry on mouse samples (fig s9). Nat Chem Biol (2020) ncbi
Santa Cruz Biotechnology
mouse monoclonal (BU63)
  • western blot; human
Santa Cruz Biotechnology B7 2 antibody (Santa Cruz, sc-19617) was used in western blot on human samples . J Biomed Mater Res A (2015) ncbi
Tonbo Biosciences
monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig s8
Tonbo Biosciences B7 2 antibody (Tonbo Biosciences, GL-1) was used in flow cytometry on mouse samples (fig s8). Adv Sci (Weinh) (2021) ncbi
monoclonal (GL-1)
  • flow cytometry; mouse; loading ...; fig 2a
Tonbo Biosciences B7 2 antibody (Tonbo Biosciences, GL-1) was used in flow cytometry on mouse samples (fig 2a). PLoS ONE (2018) ncbi
BD Biosciences
rat monoclonal (GL1)
  • flow cytometry; mouse
BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples . J Immunother Cancer (2021) ncbi
rat monoclonal (GL1)
  • other; mouse; loading ...
BD Biosciences B7 2 antibody (BD Biosciences, 553689) was used in other on mouse samples . Nat Commun (2021) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig ds1h
BD Biosciences B7 2 antibody (BD, 560582) was used in flow cytometry on mouse samples (fig ds1h). Cell Rep (2021) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 0.5 ug/ml; loading ...; fig 8b
BD Biosciences B7 2 antibody (BD, 553691) was used in flow cytometry on mouse samples at 0.5 ug/ml (fig 8b). Basic Res Cardiol (2021) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 1:300; loading ...; fig 7f
BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples at 1:300 (fig 7f). elife (2020) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 6a
BD Biosciences B7 2 antibody (BD Biosciences, 561963) was used in flow cytometry on mouse samples (fig 6a). Cell Rep (2019) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 6a
BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples (fig 6a). Front Immunol (2018) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 2:100; loading ...; fig 2a
BD Biosciences B7 2 antibody (BD Biosciences, GL-1) was used in flow cytometry on mouse samples at 2:100 (fig 2a). Biosci Rep (2019) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 2a
BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples (fig 2a). Front Immunol (2018) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 1a
BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2018) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 5b
BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples (fig 5b). Front Immunol (2018) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 4a
BD Biosciences B7 2 antibody (BD Biosciences, GL-1) was used in flow cytometry on mouse samples (fig 4a). Mucosal Immunol (2018) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig s1b
BD Biosciences B7 2 antibody (bd Biosciences, GL1) was used in flow cytometry on mouse samples (fig s1b). J Exp Med (2018) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...
In order to study the regulatory mechanism for the sex-dependent stroke mortality, BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples . Cell Immunol (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 2j
BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples (fig 2j). J Exp Med (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 1:1000; loading ...; fig s5
In order to report a CD40-dependent mechanism capable of abrogating inducible T regulatory cell induction by dendritic cells, BD Biosciences B7 2 antibody (BD Pharmingen, GL-1) was used in flow cytometry on mouse samples at 1:1000 (fig s5). Nat Commun (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 6a
In order to study the therapeutic TnP peptide in inflammation and demyelination in a mouse model of multiple sclerosis., BD Biosciences B7 2 antibody (BD Biosciences, 553692) was used in flow cytometry on mouse samples (fig 6a). PLoS ONE (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 4
BD Biosciences B7 2 antibody (BD Pharmingen, 553692) was used in flow cytometry on mouse samples (fig 4). Sci Rep (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 2
In order to study the contribution of extracellular vesicle to maternal microchimerism, BD Biosciences B7 2 antibody (BD Bioscience, GL1) was used in flow cytometry on mouse samples (fig 2). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 4c
In order to discuss the contribution of astrocytic IL-15 to postischemic brain damage, BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples (fig 4c). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 7d
In order to examine skin dendritic cells from mice exposed to two different Th2 stimuli, BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples (fig 7d). J Exp Med (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig s2
In order to explore the ability of FhHDM-1 to modulate macrophage function, BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples (fig s2). Sci Rep (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 5f
BD Biosciences B7 2 antibody (BD, GL-1) was used in flow cytometry on mouse samples (fig 5f). J Exp Med (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 1c
In order to compare gene expression profiles of the embryonic stem cell- and adult progenitor-derived dendritic cells, BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 1:200; loading ...; fig s1
In order to characterize malaria-induced splenic monocyte-derived dendritic cells, BD Biosciences B7 2 antibody (BD Bioscience, GL1) was used in flow cytometry on mouse samples at 1:200 (fig s1). Nat Commun (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 1a
BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BD Biosciences B7 2 antibody (BD, 560582) was used in flow cytometry on mouse samples . Cell (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 1
BD Biosciences B7 2 antibody (BD PharMingen, GL1) was used in flow cytometry on mouse samples (fig 1). Nat Commun (2016) ncbi
rat monoclonal (GL1)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 5d
BD Biosciences B7 2 antibody (BD Biosciences, 553689) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 5d). J Neurosci (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig s6
BD Biosciences B7 2 antibody (BD Biosciences, 560581) was used in flow cytometry on mouse samples (fig s6). Nat Commun (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 1d
BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig s4b
In order to model the expression patterns of chemokines and cytokines that turn into M1/M2 macrophage activation., BD Biosciences B7 2 antibody (BD Pharmingen, 558703) was used in flow cytometry on mouse samples (fig s4b). PLoS Comput Biol (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 1:200; loading ...; fig 5e
In order to find that coagulation factor XII modulates immune responses, BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples at 1:200 (fig 5e). Nat Commun (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 4
BD Biosciences B7 2 antibody (Becton Dickinson, GL1) was used in flow cytometry on mouse samples (fig 4). Vaccines (Basel) (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 3
BD Biosciences B7 2 antibody (BD Pharmingen, GL1) was used in flow cytometry on mouse samples (fig 3). Cell Mol Immunol (2017) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 7b
BD Biosciences B7 2 antibody (Beckon Dickinson, 560581) was used in flow cytometry on mouse samples (fig 7b). Biol Open (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; fig 3i
In order to identify a B cell-intrinsic mechanism by which IFN signaling promotes lupus pathogenesis, BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples (fig 3i). J Exp Med (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 1:100
BD Biosciences B7 2 antibody (BD Biosciences, 553691) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2016) ncbi
rat monoclonal (GL1)
  • immunocytochemistry; mouse; 1:100; fig 9
BD Biosciences B7 2 antibody (BD Biosciences, 560582) was used in immunocytochemistry on mouse samples at 1:100 (fig 9). J Immunol Res (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
BD Biosciences B7 2 antibody (BD-Biosciences, 553691) was used in flow cytometry on mouse samples . Oncoimmunology (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 2
In order to analyze induction of efficient anti-tumor immunity by vaccination with necroptotic cancer cells, BD Biosciences B7 2 antibody (BD Pharmingen, 560582) was used in flow cytometry on mouse samples (fig 2). Cell Rep (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig s7
In order to characterize promotion of an effective anti-tumor immune response by enhancing the production of type 1 interferons by 2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency in mice, BD Biosciences B7 2 antibody (BD Pharmingen, GL1) was used in flow cytometry on mouse samples (fig s7). Cancer Immunol Immunother (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 1:400; loading ...; fig 3a
In order to test if the combination of dendritic cells and doxorubicin results in tumor growth inhibition in a murine osteosarcoma model, BD Biosciences B7 2 antibody (BD Pharmingen, 558703) was used in flow cytometry on mouse samples at 1:400 (fig 3a). Oncol Lett (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 3c
In order to propose that neuronal autoimmunity is a pathogenic feature of type 1 diabetes, BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples (fig 3c). Diabetes (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 4
BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples (fig 4). Int J Oncol (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 4
In order to research the connection between oligodendrocyte death and immune-mediated CNS demyelination, BD Biosciences B7 2 antibody (BD Bioscience, 561964) was used in flow cytometry on mouse samples (fig 4). Nat Neurosci (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; loading ...; tbl s6
In order to characterize and determine the origin of arterial macrophages, BD Biosciences B7 2 antibody (BD, 553691) was used in flow cytometry on mouse samples (tbl s6). Nat Immunol (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 1
In order to investigate how Tregs are maintained in adipose tissue, BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples (fig 1). Sci Rep (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
In order to study apolipoprotein-1 during normocholesterolemic conditions, BD Biosciences B7 2 antibody (BD Pharmingen, GL1) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 4b
BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples (fig 4b). Mucosal Immunol (2016) ncbi
rat monoclonal (GL1)
  • immunocytochemistry; mouse
In order to report that carbon monoxide produced by heme-oxygenase 1 impairs DC immunogenicity using a mitochondria-dependent mechanism, BD Biosciences B7 2 antibody (BD Pharmingen, GL1) was used in immunocytochemistry on mouse samples . Eur J Immunol (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 2
  • flow cytometry; human; fig 1
In order to study B cells migration in vivo, BD Biosciences B7 2 antibody (BD Biosciences, 553692) was used in flow cytometry on mouse samples (fig 2) and in flow cytometry on human samples (fig 1). Oncoimmunology (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 7
BD Biosciences B7 2 antibody (BD Biosciences, 553692) was used in flow cytometry on mouse samples (fig 7). Exp Neurol (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 3
In order to evaluate as a mucosal vaccine platform against influenza A virus, BD Biosciences B7 2 antibody (BD Biosciences, #553692) was used in flow cytometry on mouse samples (fig 3). Front Immunol (2015) ncbi
rat monoclonal (GL1)
BD Biosciences B7 2 antibody (BD Biosciences, 561963) was used . Oncogene (2016) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
BD Biosciences B7 2 antibody (BD Biosciences, 553691) was used in flow cytometry on mouse samples . Cytometry A (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; tbl s1
In order to study the role of ICOS in group 2 innate lymphoid cell responses, BD Biosciences B7 2 antibody (BD Biosciences, GL-1) was used in flow cytometry on mouse samples (tbl s1). Biochem Biophys Res Commun (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; human
  • flow cytometry; mouse
BD Biosciences B7 2 antibody (BD Pharmingen, GL1) was used in flow cytometry on human samples and in flow cytometry on mouse samples . Cancer Immunol Res (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 2
BD Biosciences B7 2 antibody (BD Pharmingen, 553692) was used in flow cytometry on mouse samples (fig 2). Mol Med Rep (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 4
BD Biosciences B7 2 antibody (BD Pharmingen, GL1) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig s2
In order to test if injury interferes with the differentiation of antigen-specific T helper-cell responses in vivo, BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples (fig s2). Clin Sci (Lond) (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 6
BD Biosciences B7 2 antibody (BD Pharmingen, GL1) was used in flow cytometry on mouse samples (fig 6). Clin Exp Immunol (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; fig 2
In order to investigate the role of Rpl22 during early B cell development, BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
In order to test if professional antigen-presenting cell subsets and MCMV-encoded evasins alter IFN-I responses, BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples . J Virol (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
In order to investigate the role of T reg cells in exhaustion of lymphocytic choriomeningitis virus-specific CD8 T cells, BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples . Blood (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples . Int J Cancer (2015) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
BD Biosciences B7 2 antibody (BD Pharmingen, GL-1) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 1:100
BD Biosciences B7 2 antibody (BD, 553691) was used in flow cytometry on mouse samples at 1:100. PLoS ONE (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
BD Biosciences B7 2 antibody (BD Pharmingen, GL1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
BD Biosciences B7 2 antibody (BD, GL1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
BD Biosciences B7 2 antibody (BD, 553692) was used in flow cytometry on mouse samples . Exp Mol Med (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse
BD Biosciences B7 2 antibody (BD Biosciences, GL1) was used in flow cytometry on mouse samples . Int Immunol (2014) ncbi
rat monoclonal (GL1)
  • flow cytometry; mouse; 1:100
BD Biosciences B7 2 antibody (BD Biosciences, 553691) was used in flow cytometry on mouse samples at 1:100. Nat Med (2013) ncbi
rat monoclonal (GL1)
  • immunocytochemistry; mouse; 1:100
BD Biosciences B7 2 antibody (BD Biosciences, 550542) was used in immunocytochemistry on mouse samples at 1:100. Brain Behav Immun (2013) ncbi
rat monoclonal (GL1)
  • flow cytometry; human
BD Biosciences B7 2 antibody (BD Biosciences, 553691) was used in flow cytometry on human samples . J Immunol (2010) ncbi
Articles Reviewed
  1. Zhu Y, Elsheikha H, Wang J, Fang S, He J, Zhu X, et al. Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors. J Immunother Cancer. 2021;9: pubmed publisher
  2. Van Maldegem F, Valand K, Cole M, Patel H, Angelova M, Rana S, et al. Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry. Nat Commun. 2021;12:5906 pubmed publisher
  3. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  4. Kuo P, Weng W, Scofield B, Furnas D, Paraiso H, Yu I, et al. Immunoresponsive gene 1 modulates the severity of brain injury in cerebral ischaemia. Brain Commun. 2021;3:fcab187 pubmed publisher
  5. Zhang X, Chang A, Zou Y, Xu H, Cui J, Chen Z, et al. Aspirin Attenuates Cardiac Allograft Rejection by Inhibiting the Maturation of Dendritic Cells via the NF-κB Signaling Pathway. Front Pharmacol. 2021;12:706748 pubmed publisher
  6. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed publisher
  7. Guo L, Xie H, Zhang Z, Wang Z, Peng S, Niu Y, et al. Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer. Vaccines (Basel). 2021;9: pubmed publisher
  8. Hutton C, Heider F, Blanco Gómez A, Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;: pubmed publisher
  9. Bruand M, Barras D, Mina M, Ghisoni E, Morotti M, Lanitis E, et al. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 2021;36:109412 pubmed publisher
  10. Ortega Molina A, Lebrero Fernández C, Sanz A, Deleyto Seldas N, Plata Gómez A, Menéndez C, et al. Inhibition of Rag GTPase signaling in mice suppresses B cell responses and lymphomagenesis with minimal detrimental trade-offs. Cell Rep. 2021;36:109372 pubmed publisher
  11. Mai J, Li Z, Xia X, Zhang J, Li J, Liu H, et al. Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine. Adv Sci (Weinh). 2021;8:2100166 pubmed publisher
  12. Nordlohne J, Hulsmann I, Schwafertz S, Zgrajek J, Grundmann M, von Vietinghoff S, et al. A flow cytometry approach reveals heterogeneity in conventional subsets of murine renal mononuclear phagocytes. Sci Rep. 2021;11:13251 pubmed publisher
  13. Ryu S, Shchukina I, Youm Y, Qing H, Hilliard B, Dlugos T, et al. Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice. elife. 2021;10: pubmed publisher
  14. Tan H, Song Y, Chen J, Zhang N, Wang Q, Li Q, et al. Platelet-Like Fusogenic Liposome-Mediated Targeting Delivery of miR-21 Improves Myocardial Remodeling by Reprogramming Macrophages Post Myocardial Ischemia-Reperfusion Injury. Adv Sci (Weinh). 2021;8:e2100787 pubmed publisher
  15. Nakatani T, Tsujimoto K, Park J, Jo T, Kimura T, Hayama Y, et al. The lysosomal Ragulator complex plays an essential role in leukocyte trafficking by activating myosin II. Nat Commun. 2021;12:3333 pubmed publisher
  16. Okunuki Y, Tabor S, Lee M, Connor K. CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation. Front Immunol. 2021;12:680568 pubmed publisher
  17. Liu K, Jing N, Wang D, Xu P, Wang J, Chen X, et al. A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour-immune cell communication. Cell Prolif. 2021;54:e13056 pubmed publisher
  18. Frenis K, Helmstädter J, Ruan Y, Schramm E, Kalinovic S, Kröller Schön S, et al. Ablation of lysozyme M-positive cells prevents aircraft noise-induced vascular damage without improving cerebral side effects. Basic Res Cardiol. 2021;116:31 pubmed publisher
  19. Zhou J, Pei X, Yang Y, Wang Z, Gao W, Ye R, et al. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma. J Immunother Cancer. 2021;9: pubmed publisher
  20. Gangoso E, Southgate B, Bradley L, Rus S, Gálvez Cancino F, McGivern N, et al. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell. 2021;184:2454-2470.e26 pubmed publisher
  21. Sewastianik T, Straubhaar J, Zhao J, Samur M, Adler K, Tanton H, et al. miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms. Blood. 2021;137:1905-1919 pubmed publisher
  22. Chen J, Cao X, Li B, Zhao Z, Chen S, Lai S, et al. Warburg Effect Is a Cancer Immune Evasion Mechanism Against Macrophage Immunosurveillance. Front Immunol. 2020;11:621757 pubmed publisher
  23. Xu A, Barbosa R, Calado D. Genetic timestamping of plasma cells in vivo reveals tissue-specific homeostatic population turnover. elife. 2020;9: pubmed publisher
  24. Giri K, De Beaurepaire L, Jegou D, Lavy M, Mosser M, Dupont A, et al. Molecular and Functional Diversity of Distinct Subpopulations of the Stressed Insulin-Secreting Cell's Vesiculome. Front Immunol. 2020;11:1814 pubmed publisher
  25. Zhao L, Hu S, Davila M, Yang J, Lin Y, Albanese J, et al. Coordinated co-migration of CCR10+ antibody-producing B cells with helper T cells for colonic homeostatic regulation. Mucosal Immunol. 2021;14:420-430 pubmed publisher
  26. Cignarella F, Filipello F, Bollman B, Cantoni C, Locca A, Mikesell R, et al. TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis. Acta Neuropathol. 2020;140:513-534 pubmed publisher
  27. Kim E, Woodruff M, Grigoryan L, Maier B, Lee S, Mandal P, et al. Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway. elife. 2020;9: pubmed publisher
  28. Zheng D, Gao F, Cheng Q, Bao P, Dong X, Fan J, et al. A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy. Nat Commun. 2020;11:1985 pubmed publisher
  29. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed publisher
  30. Luker A, Graham L, Smith T, Camarena C, Zellner M, Gilmer J, et al. The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer. BMC Immunol. 2020;21:8 pubmed publisher
  31. Takai A, Kikuchi K, Ichimura M, Tsuneyama K, Moritoki Y, Matsumoto K, et al. Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis. BMC Gastroenterol. 2020;20:46 pubmed publisher
  32. Liang Y, Luo J, Yang N, Wang S, Ye M, Pan G. Activation of the IL-1β/KLF2/HSPH1 pathway promotes STAT3 phosphorylation in alveolar macrophages during LPS-induced acute lung injury. Biosci Rep. 2020;40: pubmed publisher
  33. Kapralov A, Yang Q, Dar H, Tyurina Y, Anthonymuthu T, Kim R, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol. 2020;16:278-290 pubmed publisher
  34. Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M, et al. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 2020;367: pubmed publisher
  35. Cohen G, Chandran P, Lorsung R, Tomlinson L, Sundby M, Burks S, et al. The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response. Cancers (Basel). 2020;12: pubmed publisher
  36. Terashima Y, Toda E, Itakura M, Otsuji M, Yoshinaga S, Okumura K, et al. Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties. Nat Commun. 2020;11:609 pubmed publisher
  37. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed publisher
  38. Ano Y, Ohya R, Takaichi Y, Washinuma T, Uchida K, Takashima A, et al. β-Lactolin, a Whey-Derived Lacto-Tetrapeptide, Prevents Alzheimer's Disease Pathologies and Cognitive Decline. J Alzheimers Dis. 2020;73:1331-1342 pubmed publisher
  39. Zhang S, Hu L, Jiang J, Li H, Wu Q, Ooi K, et al. HMGB1/RAGE axis mediates stress-induced RVLM neuroinflammation in mice via impairing mitophagy flux in microglia. J Neuroinflammation. 2020;17:15 pubmed publisher
  40. Reinhard K, Rengstl B, Oehm P, Michel K, Billmeier A, Hayduk N, et al. An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors. Science. 2020;367:446-453 pubmed publisher
  41. Eastman A, Xu J, Bermik J, Potchen N, den Dekker A, Neal L, et al. Epigenetic stabilization of DC and DC precursor classical activation by TNFα contributes to protective T cell polarization. Sci Adv. 2019;5:eaaw9051 pubmed publisher
  42. Guo C, Allen B, Hiam K, Dodd D, Van Treuren W, Higginbottom S, et al. Depletion of microbiome-derived molecules in the host using Clostridium genetics. Science. 2019;366: pubmed publisher
  43. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  44. Brown C, Gudjonson H, Pritykin Y, Deep D, Lavallée V, Mendoza A, et al. Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity. Cell. 2019;179:846-863.e24 pubmed publisher
  45. Yan D, Wang J, Sun H, Zamani A, Zhang H, Chen W, et al. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. J Exp Med. 2020;217: pubmed publisher
  46. Wolf Y, Bartok O, Patkar S, Eli G, Cohen S, Litchfield K, et al. UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma. Cell. 2019;179:219-235.e21 pubmed publisher
  47. Jia S, Li W, Liu P, Xu L. A role of eosinophils in mediating the anti-tumour effect of cryo-thermal treatment. Sci Rep. 2019;9:13214 pubmed publisher
  48. Kodumudi K, Ramamoorthi G, Snyder C, Basu A, Jia Y, Awshah S, et al. Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response. Front Immunol. 2019;10:1939 pubmed publisher
  49. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed publisher
  50. Oh J, Iijima N, Song E, Lu P, Klein J, Jiang R, et al. Migrant memory B cells secrete luminal antibody in the vagina. Nature. 2019;: pubmed publisher
  51. Sabol R, Bowles A, Côté A, Wise R, O Donnell B, Matossian M, et al. Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models. Breast Cancer Res. 2019;21:67 pubmed publisher
  52. Mizuno R, Sugiura D, Shimizu K, Maruhashi T, Watada M, Okazaki I, et al. PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation. Front Immunol. 2019;10:630 pubmed publisher
  53. Sugiura D, Maruhashi T, Okazaki I, Shimizu K, Maeda T, Takemoto T, et al. Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses. Science. 2019;364:558-566 pubmed publisher
  54. Knox T, Sahakian E, Banik D, Hadley M, Palmer E, Noonepalle S, et al. Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells. Sci Rep. 2019;9:6136 pubmed publisher
  55. Arora H, Wilcox S, Johnson L, Munro L, Eyford B, Pfeifer C, et al. The ATP-Binding Cassette Gene ABCF1 Functions as an E2 Ubiquitin-Conjugating Enzyme Controlling Macrophage Polarization to Dampen Lethal Septic Shock. Immunity. 2019;50:418-431.e6 pubmed publisher
  56. Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed publisher
  57. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  58. Lee Y, Ju J, Shon W, Oh S, Min C, Kang M, et al. Skewed Dendritic Cell Differentiation of MyD88-Deficient Donor Bone Marrow Cells, Instead of Massive Expansion as Myeloid-Derived Suppressor Cells, Aggravates GVHD. Immune Netw. 2018;18:e44 pubmed publisher
  59. Alam M, Yang D, Trivett A, Meyer T, Oppenheim J. HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways. Front Immunol. 2018;9:2982 pubmed publisher
  60. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  61. Vega Angeles V, Terrazas L, Ledesma Soto Y, Jimenez L, Landa A. Taenia solium glutathione transferase fraction activates macrophages and favors the development of Th1-type response. Biosci Rep. 2019;39: pubmed publisher
  62. Magallanes Puebla A, Espinosa Cueto P, López Marín L, Mancilla R. Mycobacterial glycolipid Di-O-acyl trehalose promotes a tolerogenic profile in dendritic cells. PLoS ONE. 2018;13:e0207202 pubmed publisher
  63. Tordesillas L, Lozano Ojalvo D, Dunkin D, Mondoulet L, Agudo J, Merad M, et al. PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs. Nat Commun. 2018;9:5238 pubmed publisher
  64. Benmerzoug S, Rose S, Bounab B, Gosset D, Duneau L, Chenuet P, et al. STING-dependent sensing of self-DNA drives silica-induced lung inflammation. Nat Commun. 2018;9:5226 pubmed publisher
  65. Hayashi T, Momota M, Kuroda E, Kusakabe T, Kobari S, Makisaka K, et al. DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination. Front Immunol. 2018;9:2619 pubmed publisher
  66. Aarts S, Seijkens T, Kusters P, Van Tiel C, Reiche M, den Toom M, et al. Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis. J Pathol. 2019;247:471-480 pubmed publisher
  67. Ushio A, Arakaki R, Otsuka K, Yamada A, Tsunematsu T, Kudo Y, et al. CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome. Front Immunol. 2018;9:2594 pubmed publisher
  68. Walker M, Crute B, Cambier J, Getahun A. B Cell-Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses. J Immunol. 2018;201:2641-2653 pubmed publisher
  69. Sang A, Danhorn T, Peterson J, Rankin A, O Connor B, Leach S, et al. Innate and adaptive signals enhance differentiation and expansion of dual-antibody autoreactive B cells in lupus. Nat Commun. 2018;9:3973 pubmed publisher
  70. Kim H, Mun Y, Lee K, Park Y, Park J, Park J, et al. T cell microvilli constitute immunological synaptosomes that carry messages to antigen-presenting cells. Nat Commun. 2018;9:3630 pubmed publisher
  71. Ko Y, Chan Y, Liu C, Liang J, Chuang T, Hsueh Y, et al. Blimp-1-Mediated Pathway Promotes Type I IFN Production in Plasmacytoid Dendritic Cells by Targeting to Interleukin-1 Receptor-Associated Kinase M. Front Immunol. 2018;9:1828 pubmed publisher
  72. Wilson K, Liu H, Healey G, Vuong V, Ishido S, Herold M, et al. MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway. PLoS ONE. 2018;13:e0200540 pubmed publisher
  73. Raso F, Sagadiev S, Du S, Gage E, Arkatkar T, Metzler G, et al. αv Integrins regulate germinal center B cell responses through noncanonical autophagy. J Clin Invest. 2018;128:4163-4178 pubmed publisher
  74. Yao Y, Huang W, Li X, Li X, Qian J, Han H, et al. Tespa1 Deficiency Dampens Thymus-Dependent B-Cell Activation and Attenuates Collagen-Induced Arthritis in Mice. Front Immunol. 2018;9:965 pubmed publisher
  75. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  76. García Nores G, Ly C, Cuzzone D, Kataru R, Hespe G, Torrisi J, et al. CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema. Nat Commun. 2018;9:1970 pubmed publisher
  77. Singla B, Ghoshal P, Lin H, Wei Q, Dong Z, Csanyi G. PKCδ-Mediated Nox2 Activation Promotes Fluid-Phase Pinocytosis of Antigens by Immature Dendritic Cells. Front Immunol. 2018;9:537 pubmed publisher
  78. Mencarelli A, Khameneh H, Fric J, Vacca M, El Daker S, Janela B, et al. Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis. Nat Commun. 2018;9:1102 pubmed publisher
  79. Macdougall C, Wood E, Loschko J, Scagliotti V, Cassidy F, Robinson M, et al. Visceral Adipose Tissue Immune Homeostasis Is Regulated by the Crosstalk between Adipocytes and Dendritic Cell Subsets. Cell Metab. 2018;27:588-601.e4 pubmed publisher
  80. Yeh C, Nojima T, Kuraoka M, Kelsoe G. Germinal center entry not selection of B cells is controlled by peptide-MHCII complex density. Nat Commun. 2018;9:928 pubmed publisher
  81. Trapecar M, Khan S, Cohn B, Wu F, Sanjabi S. B cells are the predominant mediators of early systemic viral dissemination during rectal LCMV infection. Mucosal Immunol. 2018;11:1158-1167 pubmed publisher
  82. Perry C, Muñoz Rojas A, Meeth K, Kellman L, Amezquita R, Thakral D, et al. Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med. 2018;215:877-893 pubmed publisher
  83. Turner D, Goldklang M, Cvetkovski F, Paik D, Trischler J, Barahona J, et al. Biased Generation and In Situ Activation of Lung Tissue-Resident Memory CD4 T Cells in the Pathogenesis of Allergic Asthma. J Immunol. 2018;200:1561-1569 pubmed publisher
  84. Capucha T, Koren N, Nassar M, Heyman O, Nir T, Levy M, et al. Sequential BMP7/TGF-β1 signaling and microbiota instruct mucosal Langerhans cell differentiation. J Exp Med. 2018;215:481-500 pubmed publisher
  85. Christ A, Günther P, Lauterbach M, Duewell P, Biswas D, Pelka K, et al. Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming. Cell. 2018;172:162-175.e14 pubmed publisher
  86. Leonardi I, Li X, Semon A, Li D, Doron I, Putzel G, et al. CX3CR1+ mononuclear phagocytes control immunity to intestinal fungi. Science. 2018;359:232-236 pubmed publisher
  87. Pedros C, Canonigo Balancio A, Kong K, Altman A. Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity. JCI Insight. 2017;2: pubmed publisher
  88. Wasiuk A, Testa J, Weidlick J, Sisson C, Vitale L, Widger J, et al. CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy. J Immunol. 2017;199:4110-4123 pubmed publisher
  89. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  90. Purvis H, Clarke F, Jordan C, Blanco C, Cornish G, Dai X, et al. Protein tyrosine phosphatase PTPN22 regulates IL-1β dependent Th17 responses by modulating dectin-1 signaling in mice. Eur J Immunol. 2018;48:306-315 pubmed publisher
  91. Giampazolias E, Zunino B, Dhayade S, Bock F, Cloix C, Cao K, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116-1129 pubmed publisher
  92. Akiel M, Guo C, Li X, Rajasekaran D, Mendoza R, Robertson C, et al. IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Res. 2017;77:4014-4025 pubmed publisher
  93. Seifert H, Benedek G, Liang J, Nguyen H, Kent G, Vandenbark A, et al. Sex differences in regulatory cells in experimental stroke. Cell Immunol. 2017;318:49-54 pubmed publisher
  94. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  95. Shrestha B, You D, Saravia J, Siefker D, Jaligama S, Lee G, et al. IL-4R? on dendritic cells in neonates and Th2 immunopathology in respiratory syncytial virus infection. J Leukoc Biol. 2017;102:153-161 pubmed publisher
  96. van der Vlugt L, Obieglo K, Ozir Fazalalikhan A, Sparwasser T, Haeberlein S, Smits H. Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function. Int J Parasitol. 2017;47:545-554 pubmed publisher
  97. Kitada S, Kayama H, Okuzaki D, Koga R, Kobayashi M, Arima Y, et al. BATF2 inhibits immunopathological Th17 responses by suppressing Il23a expression during Trypanosoma cruzi infection. J Exp Med. 2017;214:1313-1331 pubmed publisher
  98. Schweighoffer E, Nys J, Vanes L, Smithers N, Tybulewicz V. TLR4 signals in B lymphocytes are transduced via the B cell antigen receptor and SYK. J Exp Med. 2017;214:1269-1280 pubmed publisher
  99. Inoue T, Shinnakasu R, Ise W, Kawai C, Egawa T, Kurosaki T. The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help. J Exp Med. 2017;214:1181-1198 pubmed publisher
  100. Getahun A, Wemlinger S, Rudra P, Santiago M, van Dyk L, Cambier J. Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway. J Exp Med. 2017;214:931-941 pubmed publisher
  101. Kogo H, Shimizu M, Negishi Y, Uchida E, Takahashi H. Suppression of murine tumour growth through CD8+ cytotoxic T lymphocytes via activated DEC-205+ dendritic cells by sequential administration of ?-galactosylceramide in vivo. Immunology. 2017;151:324-339 pubmed publisher
  102. Srinivasan S, Su M, Ravishankar S, Moore J, Head P, Dixon J, et al. TLR-exosomes exhibit distinct kinetics and effector function. Sci Rep. 2017;7:41623 pubmed publisher
  103. Barthels C, Ogrinc A, Steyer V, Meier S, Simon F, Wimmer M, et al. CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis. Nat Commun. 2017;8:14715 pubmed publisher
  104. Baranek T, Morello E, Valayer A, Aimar R, Bréa D, Henry C, et al. FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection. Front Immunol. 2017;8:123 pubmed publisher
  105. Komegae E, Souza T, Grund L, Lima C, Lopes Ferreira M. Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis. PLoS ONE. 2017;12:e0171796 pubmed publisher
  106. Perez Ruiz de Garibay A, Spinato C, Klippstein R, Bourgognon M, Martincic M, Pach E, et al. Evaluation of the immunological profile of antibody-functionalized metal-filled single-walled carbon nanocapsules for targeted radiotherapy. Sci Rep. 2017;7:42605 pubmed publisher
  107. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed publisher
  108. Laidlaw B, Schmidt T, Green J, Allen C, Okada T, Cyster J. The Eph-related tyrosine kinase ligand Ephrin-B1 marks germinal center and memory precursor B cells. J Exp Med. 2017;214:639-649 pubmed publisher
  109. Gomaa A, El Aziz E. Vitamin D reduces high-fat diet induced weight gain and C-reactive protein, increases interleukin-10, and reduces CD86 and caspase-3. Pathophysiology. 2017;24:31-37 pubmed publisher
  110. Zhu Y, Lyapichev K, Lee D, Motti D, Ferraro N, Zhang Y, et al. Macrophage Transcriptional Profile Identifies Lipid Catabolic Pathways That Can Be Therapeutically Targeted after Spinal Cord Injury. J Neurosci. 2017;37:2362-2376 pubmed publisher
  111. Vander Lugt B, Riddell J, Khan A, Hackney J, Lesch J, DeVoss J, et al. Transcriptional determinants of tolerogenic and immunogenic states during dendritic cell maturation. J Cell Biol. 2017;216:779-792 pubmed publisher
  112. Bracamonte Baran W, Florentin J, Zhou Y, Jankowska Gan E, Haynes W, Zhong W, et al. Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance. Proc Natl Acad Sci U S A. 2017;114:1099-1104 pubmed publisher
  113. Troegeler A, Mercier I, Cougoule C, Pietretti D, Colom A, Duval C, et al. C-type lectin receptor DCIR modulates immunity to tuberculosis by sustaining type I interferon signaling in dendritic cells. Proc Natl Acad Sci U S A. 2017;114:E540-E549 pubmed publisher
  114. Hellström Erkenstam N, Smith P, Fleiss B, Nair S, Svedin P, Wang W, et al. Temporal Characterization of Microglia/Macrophage Phenotypes in a Mouse Model of Neonatal Hypoxic-Ischemic Brain Injury. Front Cell Neurosci. 2016;10:286 pubmed publisher
  115. Li M, Li Z, Yao Y, Jin W, Wood K, Liu Q, et al. Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity. Proc Natl Acad Sci U S A. 2017;114:E396-E405 pubmed publisher
  116. Connor L, Tang S, Cognard E, Ochiai S, Hilligan K, Old S, et al. Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles. J Exp Med. 2017;214:125-142 pubmed publisher
  117. Yokota Nakatsuma A, Ohoka Y, Takeuchi H, Song S, Iwata M. Beta 1-integrin ligation and TLR ligation enhance GM-CSF-induced ALDH1A2 expression in dendritic cells, but differentially regulate their anti-inflammatory properties. Sci Rep. 2016;6:37914 pubmed publisher
  118. Lund M, Greer J, Dixit A, Alvarado R, McCauley Winter P, To J, et al. A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis. Sci Rep. 2016;6:37789 pubmed publisher
  119. Tahiri H, Omri S, Yang C, Duhamel F, Samarani S, Ahmad A, et al. Lymphocytic Microparticles Modulate Angiogenic Properties of Macrophages in Laser-induced Choroidal Neovascularization. Sci Rep. 2016;6:37391 pubmed publisher
  120. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  121. Sulek J, Robinson S, Petrossian A, Zhou S, Goliadze E, Manjili M, et al. Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model. Prostate. 2017;77:361-373 pubmed publisher
  122. Khan S, Woodruff E, Trapecar M, Fontaine K, Ezaki A, Borbet T, et al. Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication. J Exp Med. 2016;213:2913-2929 pubmed
  123. Takács E, Boto P, Simo E, Csuth T, Toth B, Raveh Amit H, et al. Immunogenic Dendritic Cell Generation from Pluripotent Stem Cells by Ectopic Expression of Runx3. J Immunol. 2017;198:239-248 pubmed
  124. Theisen E, Sauer J. Listeria monocytogenes-Induced Cell Death Inhibits the Generation of Cell-Mediated Immunity. Infect Immun. 2017;85: pubmed publisher
  125. Hirako I, Ataide M, Faustino L, Assis P, Sorensen E, Ueta H, et al. Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria. Nat Commun. 2016;7:13277 pubmed publisher
  126. Calmette J, Bertrand M, Vétillard M, Ellouze M, Flint S, Nicolas V, et al. Glucocorticoid-Induced Leucine Zipper Protein Controls Macropinocytosis in Dendritic Cells. J Immunol. 2016;197:4247-4256 pubmed
  127. Smirnova T, Bonapace L, MacDonald G, Kondo S, Wyckoff J, Ebersbach H, et al. Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages. Oncotarget. 2016;7:82289-82304 pubmed publisher
  128. Zhao J, Chen C, Guo M, Tao Y, Cui P, Zhou Y, et al. MicroRNA-7 Deficiency Ameliorates the Pathologies of Acute Lung Injury through Elevating KLF4. Front Immunol. 2016;7:389 pubmed
  129. Zhou Z, Tang Y, Jin X, Chen C, Lu Y, Liu L, et al. Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NF?B Pathway Suppression. J Diabetes Res. 2016;2016:4847812 pubmed
  130. Jones D, Gaudette B, Wilmore J, Chernova I, Bortnick A, Weiss B, et al. mTOR has distinct functions in generating versus sustaining humoral immunity. J Clin Invest. 2016;126:4250-4261 pubmed publisher
  131. Collinson Pautz M, Slawin K, Levitt J, Spencer D. MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity. PLoS ONE. 2016;11:e0164547 pubmed publisher
  132. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  133. Papadaki G, Kambas K, Choulaki C, Vlachou K, Drakos E, Bertsias G, et al. Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation. Eur J Immunol. 2016;46:2542-2554 pubmed publisher
  134. Wu J, Wu H, Tsai D, Chiang M, Chen Y, Gao S, et al. Temporal regulation of Lsp1 O-GlcNAcylation and phosphorylation during apoptosis of activated B cells. Nat Commun. 2016;7:12526 pubmed publisher
  135. Kouwenberg M, Jacobs C, van der Vlag J, Hilbrands L. Allostimulatory Effects of Dendritic Cells with Characteristic Features of a Regulatory Phenotype. PLoS ONE. 2016;11:e0159986 pubmed publisher
  136. Gaudet A, Mandrekar Colucci S, Hall J, Sweet D, Schmitt P, Xu X, et al. miR-155 Deletion in Mice Overcomes Neuron-Intrinsic and Neuron-Extrinsic Barriers to Spinal Cord Repair. J Neurosci. 2016;36:8516-32 pubmed publisher
  137. Zhao Y, Chu X, Chen J, Wang Y, Gao S, Jiang Y, et al. Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells. Nat Commun. 2016;7:12368 pubmed publisher
  138. Pizzolla A, Oh D, Luong S, Prickett S, Henstridge D, Febbraio M, et al. High Fat Diet Inhibits Dendritic Cell and T Cell Response to Allergens but Does Not Impair Inhalational Respiratory Tolerance. PLoS ONE. 2016;11:e0160407 pubmed publisher
  139. Chow K, Delconte R, Huntington N, Tarlinton D, Sutherland R, Zhan Y, et al. Innate Allorecognition Results in Rapid Accumulation of Monocyte-Derived Dendritic Cells. J Immunol. 2016;197:2000-8 pubmed publisher
  140. Veinotte L, Gebremeskel S, Johnston B. CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFN? production and tumor control. Oncoimmunology. 2016;5:e1160979 pubmed publisher
  141. Rex J, Albrecht U, Ehlting C, Thomas M, Zanger U, Sawodny O, et al. Model-Based Characterization of Inflammatory Gene Expression Patterns of Activated Macrophages. PLoS Comput Biol. 2016;12:e1005018 pubmed publisher
  142. Chen S, Miyazaki M, Chandra V, Fisch K, Chang A, Murre C. Id3 Orchestrates Germinal Center B Cell Development. Mol Cell Biol. 2016;36:2543-52 pubmed publisher
  143. Parsa R, Lund H, Georgoudaki A, Zhang X, Ortlieb Guerreiro Cacais A, Grommisch D, et al. BAFF-secreting neutrophils drive plasma cell responses during emergency granulopoiesis. J Exp Med. 2016;213:1537-53 pubmed publisher
  144. Lo T, Silveira P, Fromm P, Verma N, Vu P, Kupresanin F, et al. Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration. J Immunol. 2016;197:885-98 pubmed publisher
  145. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed publisher
  146. Chikh G, Luu R, Patel S, Davis H, Weeratna R. Effects of KLK Peptide on Adjuvanticity of Different ODN Sequences. Vaccines (Basel). 2016;4: pubmed publisher
  147. Wen S, Dooner M, Cheng Y, Papa E, Del Tatto M, Pereira M, et al. Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells. Leukemia. 2016;30:2221-2231 pubmed publisher
  148. Xu X, Meng Q, Erben U, Wang P, Glauben R, Kuhl A, et al. Myeloid-derived suppressor cells promote B-cell production of IgA in a TNFR2-dependent manner. Cell Mol Immunol. 2017;14:597-606 pubmed publisher
  149. Salao K, Jiang L, Li H, Tsai V, Husaini Y, Curmi P, et al. CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis. Biol Open. 2016;5:620-30 pubmed publisher
  150. Anghelina D, Lam E, Falck Pedersen E. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity. J Virol. 2016;90:5915-27 pubmed publisher
  151. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed publisher
  152. Uto T, Fukaya T, Takagi H, Arimura K, Nakamura T, Kojima N, et al. Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity. Nat Commun. 2016;7:11273 pubmed publisher
  153. Ufimtseva E. Differences between Mycobacterium-Host Cell Relationships in Latent Tuberculous Infection of Mice Ex Vivo and Mycobacterial Infection of Mouse Cells In Vitro. J Immunol Res. 2016;2016:4325646 pubmed publisher
  154. Vandenberk L, Garg A, Verschuere T, Koks C, Belmans J, Beullens M, et al. Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma. Oncoimmunology. 2016;5:e1083669 pubmed
  155. Llopiz D, Aranda F, Díaz Valdés N, Ruiz M, Infante S, Belsue V, et al. Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination. Oncoimmunology. 2016;5:e1075113 pubmed
  156. Aaes T, Kaczmarek A, Delvaeye T, De Craene B, De Koker S, Heyndrickx L, et al. Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity. Cell Rep. 2016;15:274-87 pubmed publisher
  157. Sim C, Cho Y, Kim B, Baek I, Kim Y, Lee M. 2'-5' Oligoadenylate synthetase-like 1 (OASL1) deficiency in mice promotes an effective anti-tumor immune response by enhancing the production of type I interferons. Cancer Immunol Immunother. 2016;65:663-75 pubmed publisher
  158. Kawano M, Tanaka K, Itonaga I, Iwasaki T, Miyazaki M, Ikeda S, et al. Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma. Oncol Lett. 2016;11:2169-2175 pubmed
  159. Lee Chang C, Bodogai M, Moritoh K, Chen X, Wersto R, Sen R, et al. Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers. J Immunol. 2016;196:3385-97 pubmed publisher
  160. Leeth C, Racine J, Chapman H, Arpa B, Carrillo J, Carrascal J, et al. B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice. Diabetes. 2016;65:1977-1987 pubmed publisher
  161. Flach A, Litke T, Strauss J, Haberl M, Gómez C, Reindl M, et al. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci U S A. 2016;113:3323-8 pubmed publisher
  162. Gabunia K, Ellison S, Kelemen S, Kako F, Cornwell W, Rogers T, et al. IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages. Am J Pathol. 2016;186:1361-74 pubmed publisher
  163. Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt E, et al. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. J Immunol. 2016;196:3305-17 pubmed publisher
  164. Levit Zerdoun E, Becker M, Pohlmeyer R, Wilhelm I, Maity P, Rajewsky K, et al. Survival of Igα-Deficient Mature B Cells Requires BAFF-R Function. J Immunol. 2016;196:2348-60 pubmed publisher
  165. Ying W, Tseng A, Chang R, Wang H, Lin Y, Kanameni S, et al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176 pubmed publisher
  166. Lasigliè D, Boero S, Bauer I, Morando S, Damonte P, Cea M, et al. Sirt6 regulates dendritic cell differentiation, maturation, and function. Aging (Albany NY). 2016;8:34-49 pubmed
  167. Mikyšková R, Štěpánek I, Indrová M, Bieblová J, Šímová J, Truxová I, et al. Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy. Int J Oncol. 2016;48:953-64 pubmed publisher
  168. Pylayeva Gupta Y, Das S, Handler J, Hajdu C, Coffre M, Koralov S, et al. IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia. Cancer Discov. 2016;6:247-55 pubmed publisher
  169. Traka M, Podojil J, McCarthy D, Miller S, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci. 2016;19:65-74 pubmed publisher
  170. Ensan S, Li A, Besla R, Degousee N, Cosme J, Roufaiel M, et al. Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth. Nat Immunol. 2016;17:159-68 pubmed publisher
  171. Schachtner H, Weimershaus M, Stache V, Plewa N, Legler D, Höpken U, et al. Loss of Gadkin Affects Dendritic Cell Migration In Vitro. PLoS ONE. 2015;10:e0143883 pubmed publisher
  172. Onodera T, Fukuhara A, Jang M, Shin J, Aoi K, Kikuta J, et al. Adipose tissue macrophages induce PPARγ-high FOXP3(+) regulatory T cells. Sci Rep. 2015;5:16801 pubmed publisher
  173. Fontinha D, Lopes F, Marques S, Alenquer M, Simas J. Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells. PLoS ONE. 2015;10:e0142540 pubmed publisher
  174. Black L, Srivastava R, Schoeb T, Moore R, Barnes S, KABAROWSKI J. Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice. J Immunol. 2015;195:4685-98 pubmed publisher
  175. Wu V, Smith A, You H, Nguyen T, Ferguson R, Taylor M, et al. Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice. Mucosal Immunol. 2016;9:777-86 pubmed publisher
  176. Riquelme S, Pogu J, Anegon I, Bueno S, Kalergis A. Carbon monoxide impairs mitochondria-dependent endosomal maturation and antigen presentation in dendritic cells. Eur J Immunol. 2015;45:3269-88 pubmed publisher
  177. Pohar J, Lainšček D, Fukui R, Yamamoto C, Miyake K, Jerala R, et al. Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9. J Immunol. 2015;195:4396-405 pubmed publisher
  178. Gonzalez N, Wennhold K, Balkow S, Kondo E, Bölck B, Weber T, et al. In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy. Oncoimmunology. 2015;4:e1038684 pubmed
  179. Eitan E, Hutchison E, Greig N, Tweedie D, Celik H, Ghosh S, et al. Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity. Exp Neurol. 2015;273:151-60 pubmed publisher
  180. Yang H, Yamazaki T, Pietrocola F, Zhou H, Zitvogel L, Ma Y, et al. STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells. Cancer Res. 2015;75:3812-22 pubmed publisher
  181. Vogel A, Brown D. Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells. Front Immunol. 2015;6:327 pubmed publisher
  182. Napolitano A, Pellegrini L, Dey A, Larson D, Tanji M, Flores E, et al. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene. 2016;35:1996-2002 pubmed publisher
  183. Jin X, Yao T, Zhou Z, Zhu J, Zhang S, Hu W, et al. Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway. Biomed Res Int. 2015;2015:732450 pubmed publisher
  184. Keswani R, Yoon G, Sud S, Stringer K, Rosania G. A far-red fluorescent probe for flow cytometry and image-based functional studies of xenobiotic sequestering macrophages. Cytometry A. 2015;87:855-67 pubmed publisher
  185. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed publisher
  186. Holtzhausen A, Zhao F, Evans K, Tsutsui M, Orabona C, Tyler D, et al. Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy. Cancer Immunol Res. 2015;3:1082-95 pubmed publisher
  187. Williams B, Tebbutt N, Buchert M, Putoczki T, Doggett K, Bao S, et al. Glycoprotein A33 deficiency: a new mouse model of impaired intestinal epithelial barrier function and inflammatory disease. Dis Model Mech. 2015;8:805-15 pubmed publisher
  188. Liechtenstein T, Perez Janices N, Blanco Luquin I, Goyvaerts C, Schwarze J, Dufait I, et al. Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy. Oncoimmunology. 2014;3:e945378 pubmed
  189. Zeng S, Wang L, Li P, Wang W, Yang J. Mesenchymal stem cells abrogate experimental asthma by altering dendritic cell function. Mol Med Rep. 2015;12:2511-20 pubmed publisher
  190. Carmi Y, Spitzer M, Linde I, Burt B, Prestwood T, Perlman N, et al. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 2015;521:99-104 pubmed publisher
  191. Sharma S, Chintala N, Vadrevu S, Patel J, Karbowniczek M, Markiewski M. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs. J Immunol. 2015;194:5529-38 pubmed publisher
  192. Hamilton J, Li J, Wu Q, Yang P, Luo B, Li H, et al. General Approach for Tetramer-Based Identification of Autoantigen-Reactive B Cells: Characterization of La- and snRNP-Reactive B Cells in Autoimmune BXD2 Mice. J Immunol. 2015;194:5022-34 pubmed publisher
  193. Kolan S, Boman A, Matozaki T, Lejon K, Oldenborg P. Lack of non-hematopoietic SIRPα signaling disturbs the splenic marginal zone architecture resulting in accumulation and displacement of marginal zone B cells. Biochem Biophys Res Commun. 2015;460:645-50 pubmed publisher
  194. Wong E, Soni C, Chan A, Domeier P, Shwetank -, Abraham T, et al. B cell-intrinsic CD84 and Ly108 maintain germinal center B cell tolerance. J Immunol. 2015;194:4130-43 pubmed publisher
  195. Dudek Perić A, Ferreira G, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res. 2015;75:1603-14 pubmed publisher
  196. Wensveen F, Jelenčić V, Valentić S, Šestan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed publisher
  197. Jobsri J, Allen A, Rajagopal D, Shipton M, Kanyuka K, Lomonossoff G, et al. Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody. PLoS ONE. 2015;10:e0118096 pubmed publisher
  198. Pannu J, Belle J, Forster M, Duerr C, Shen S, Kane L, et al. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS ONE. 2015;10:e0117304 pubmed publisher
  199. Sun H, Zhang J, Chen F, Chen X, Zhou Z, Wang H. Activation of RAW264.7 macrophages by the polysaccharide from the roots of Actinidia eriantha and its molecular mechanisms. Carbohydr Polym. 2015;121:388-402 pubmed publisher
  200. McKay J, Egan R, Yammani R, Chen L, Shin T, Yagita H, et al. PD-1 suppresses protective immunity to Streptococcus pneumoniae through a B cell-intrinsic mechanism. J Immunol. 2015;194:2289-99 pubmed publisher
  201. Wirsdörfer F, Bangen J, Pastille E, Hansen W, Flohé S. Breaking the co-operation between bystander T-cells and natural killer cells prevents the development of immunosuppression after traumatic skeletal muscle injury in mice. Clin Sci (Lond). 2015;128:825-38 pubmed publisher
  202. Ikeda T, Hirata S, Takamatsu K, Haruta M, Tsukamoto H, Ito T, et al. Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells. PLoS ONE. 2014;9:e115198 pubmed publisher
  203. White C, Villarino N, Sloan S, Ganusov V, Schmidt N. Plasmodium suppresses expansion of T cell responses to heterologous infections. J Immunol. 2015;194:697-708 pubmed publisher
  204. Yin Y, Qin T, Wang X, Lin J, Yu Q, Yang Q. CpG DNA assists the whole inactivated H9N2 influenza virus in crossing the intestinal epithelial barriers via transepithelial uptake of dendritic cell dendrites. Mucosal Immunol. 2015;8:799-814 pubmed publisher
  205. Kim J, Li W, Choi Y, Lewin S, Verbeke C, Dranoff G, et al. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. Nat Biotechnol. 2015;33:64-72 pubmed publisher
  206. Hou J, Zhang Q, Fujino M, Cai S, Ito H, Takahashi K, et al. 5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells. J Heart Lung Transplant. 2015;34:254-63 pubmed publisher
  207. Cousens L, Najafian N, Martin W, De Groot A. Tregitope: Immunomodulation powerhouse. Hum Immunol. 2014;75:1139-46 pubmed publisher
  208. Frossard C, Asigbetse K, Burger D, Eigenmann P. Gut T cell receptor-γδ(+) intraepithelial lymphocytes are activated selectively by cholera toxin to break oral tolerance in mice. Clin Exp Immunol. 2015;180:118-30 pubmed publisher
  209. Fahl S, Harris B, Coffey F, Wiest D. Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint. J Immunol. 2015;194:200-9 pubmed
  210. McDonnell A, Lesterhuis W, Khong A, Nowak A, Lake R, Currie A, et al. Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy. Eur J Immunol. 2015;45:49-59 pubmed publisher
  211. Škrnjug I, Guzmán C, Rueckert C, Ruecker C. Cyclic GMP-AMP displays mucosal adjuvant activity in mice. PLoS ONE. 2014;9:e110150 pubmed publisher
  212. Döring M, Lessin I, Frenz T, Spanier J, Kessler A, Tegtmeyer P, et al. M27 expressed by cytomegalovirus counteracts effective type I interferon induction of myeloid cells but not of plasmacytoid dendritic cells. J Virol. 2014;88:13638-50 pubmed publisher
  213. Chen M, Chen Y, Wu M, Yu G, Lin W, Tan T, et al. PP4 is essential for germinal center formation and class switch recombination in mice. PLoS ONE. 2014;9:e107505 pubmed publisher
  214. Wei F, Yang D, Tewary P, Li Y, Li S, Chen X, et al. The Alarmin HMGN1 contributes to antitumor immunity and is a potent immunoadjuvant. Cancer Res. 2014;74:5989-98 pubmed publisher
  215. Dai M, Yip Y, Hellstrom I, Hellstrom K. Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies. Clin Cancer Res. 2015;21:1127-38 pubmed publisher
  216. Penaloza MacMaster P, Kamphorst A, Wieland A, Araki K, Iyer S, West E, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014;211:1905-18 pubmed publisher
  217. McNally A, Anderson J. Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties. J Biomed Mater Res A. 2015;103:1380-90 pubmed publisher
  218. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  219. Siurala M, Bramante S, Vassilev L, Hirvinen M, Parviainen S, Tähtinen S, et al. Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma. Int J Cancer. 2015;136:945-54 pubmed publisher
  220. Zhou Q, Ho A, Schlitzer A, Tang Y, Wong K, Wong F, et al. GM-CSF-licensed CD11b+ lung dendritic cells orchestrate Th2 immunity to Blomia tropicalis. J Immunol. 2014;193:496-509 pubmed publisher
  221. Moreno M, Bannerman P, Ma J, Guo F, Miers L, Soulika A, et al. Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE. J Neurosci. 2014;34:8175-85 pubmed publisher
  222. Alsadeq A, Hobeika E, Medgyesi D, Kläsener K, Reth M. The role of the Syk/Shp-1 kinase-phosphatase equilibrium in B cell development and signaling. J Immunol. 2014;193:268-76 pubmed publisher
  223. Assi H, Espinosa J, Suprise S, SOFRONIEW M, Doherty R, Zamler D, et al. Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBM. PLoS ONE. 2014;9:e96318 pubmed publisher
  224. Qian L, Zhang M, Wu S, Zhong Y, Van Tol E, Cai W. Alkylglycerols modulate the proliferation and differentiation of non-specific agonist and specific antigen-stimulated splenic lymphocytes. PLoS ONE. 2014;9:e96207 pubmed publisher
  225. Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman C. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS ONE. 2014;9:e95728 pubmed publisher
  226. Sheng K, Herrero L, Taylor A, Hapel A, Mahalingam S. IL-3 and CSF-1 interact to promote generation of CD11c+ IL-10-producing macrophages. PLoS ONE. 2014;9:e95208 pubmed publisher
  227. Dupont C, Christian D, Selleck E, Pepper M, Leney Greene M, Harms Pritchard G, et al. Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii. PLoS Pathog. 2014;10:e1004047 pubmed publisher
  228. Hirayama T, Asano Y, Iida H, Watanabe T, Nakamura T, Goitsuka R. Meis1 is required for the maintenance of postnatal thymic epithelial cells. PLoS ONE. 2014;9:e89885 pubmed publisher
  229. Ramakrishnan R, Tyurin V, Tuyrin V, Veglia F, Condamine T, Amoscato A, et al. Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. J Immunol. 2014;192:2920-31 pubmed publisher
  230. Jin Y, Wi H, Choi M, Hong S, Bae Y. Regulation of anti-inflammatory cytokines IL-10 and TGF-? in mouse dendritic cells through treatment with Clonorchis sinensis crude antigen. Exp Mol Med. 2014;46:e74 pubmed publisher
  231. Mercadante A, Perobelli S, Alves A, Gonçalves Silva T, Mello W, Gomes Santos A, et al. Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance. J Immunol. 2014;192:1928-37 pubmed publisher
  232. Yang M, Rainone A, Shi X, Fournier S, Zhang J. A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome. Acta Neuropathol Commun. 2014;2:5 pubmed publisher
  233. Iwata A, Kawashima S, Kobayashi M, Okubo A, Kawashima H, Suto A, et al. Th2-type inflammation instructs inflammatory dendritic cells to induce airway hyperreactivity. Int Immunol. 2014;26:103-14 pubmed publisher
  234. Harimoto H, Shimizu M, Nakagawa Y, Nakatsuka K, Wakabayashi A, Sakamoto C, et al. Inactivation of tumor-specific CD8? CTLs by tumor-infiltrating tolerogenic dendritic cells. Immunol Cell Biol. 2013;91:545-55 pubmed publisher
  235. Bittner S, Ruck T, Schuhmann M, Herrmann A, Moha Ou Maati H, Bobak N, et al. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med. 2013;19:1161-5 pubmed publisher
  236. Chhor V, Le Charpentier T, Lebon S, Oré M, Celador I, Josserand J, et al. Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav Immun. 2013;32:70-85 pubmed publisher
  237. Khan A, Fu H, Tan L, Harper J, Beutelspacher S, Larkin D, et al. Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition. Eur J Immunol. 2013;43:734-46 pubmed publisher
  238. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed publisher
  239. Charles E, Joshi S, Ash J, Fox B, Farris A, Bzik D, et al. CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1. Infect Immun. 2010;78:3484-92 pubmed publisher
  240. Sadri N, Lu J, Badura M, Schneider R. AUF1 is involved in splenic follicular B cell maintenance. BMC Immunol. 2010;11:1 pubmed publisher
  241. Schuhmann M, Stegner D, Berna Erro A, Bittner S, Braun A, Kleinschnitz C, et al. Stromal interaction molecules 1 and 2 are key regulators of autoreactive T cell activation in murine autoimmune central nervous system inflammation. J Immunol. 2010;184:1536-42 pubmed publisher
  242. Siegemund S, Hartl A, von Buttlar H, Dautel F, Raue R, Freudenberg M, et al. Conventional bone marrow-derived dendritic cells contribute to toll-like receptor-independent production of alpha/beta interferon in response to inactivated parapoxvirus ovis. J Virol. 2009;83:9411-22 pubmed publisher
  243. Ellestad K, Tsutsui S, Noorbakhsh F, Warren K, Yong V, Pittman Q, et al. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J Immunol. 2009;183:298-309 pubmed publisher
  244. Kiesel J, Buchwald Z, Aurora R. Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells. J Immunol. 2009;182:5477-87 pubmed publisher
  245. Blumenthal A, Kobayashi T, Pierini L, Banaei N, Ernst J, Miyake K, et al. RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins. Cell Host Microbe. 2009;5:35-46 pubmed publisher
  246. Hamazaki Y, Fujita H, Kobayashi T, Choi Y, Scott H, Matsumoto M, et al. Medullary thymic epithelial cells expressing Aire represent a unique lineage derived from cells expressing claudin. Nat Immunol. 2007;8:304-11 pubmed
  247. Hewitson J, Jenkins G, Hamblin P, Mountford A. CD40/CD154 interactions are required for the optimal maturation of skin-derived APCs and the induction of helminth-specific IFN-gamma but not IL-4. J Immunol. 2006;177:3209-17 pubmed
  248. Zhang J, Raper A, Sugita N, Hingorani R, Salio M, Palmowski M, et al. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood. 2006;107:3600-8 pubmed
  249. Hoffmann P, Kench J, Vondracek A, Kruk E, Daleke D, Jordan M, et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol. 2005;174:1393-404 pubmed
  250. Jenkins S, Mountford A. Dendritic cells activated with products released by schistosome larvae drive Th2-type immune responses, which can be inhibited by manipulation of CD40 costimulation. Infect Immun. 2005;73:395-402 pubmed
  251. Hogg K, Kumkate S, Mountford A. IL-10 regulates early IL-12-mediated immune responses induced by the radiation-attenuated schistosome vaccine. Int Immunol. 2003;15:1451-9 pubmed
  252. Morin J, Faideau B, Gagnerault M, Lepault F, Boitard C, Boudaly S. Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice. Clin Exp Immunol. 2003;134:388-95 pubmed
  253. Cabatingan M, Schmidt M, Sen R, Woodland R. Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit. J Immunol. 2002;169:6795-805 pubmed
  254. Magner W, Kazim A, Stewart C, Romano M, Catalano G, Grande C, et al. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol. 2000;165:7017-24 pubmed
  255. Knobeloch K, Wright M, Ochsenbein A, Liesenfeld O, Lohler J, Zinkernagel R, et al. Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions. Mol Cell Biol. 2000;20:5363-9 pubmed
  256. Bauman S, Nichols K, Murphy J. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses. J Immunol. 2000;165:158-67 pubmed